Manske Wealth Management’s AbbVie ABBV Stock Holding History

Manske Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$477K	Buy	1,894 +25	+1%	+$5.38K	0.12%	139
2026 Q1	$406K	Sell	1,869 -79	-4%	-$17.5K	0.11%	143
2025 Q4	$445K	Sell	1,948 -20	-1%	-$4.56K	0.13%	124
2025 Q3	$456K	Hold	1,968	–	–	0.14%	119
2025 Q2	$365K	Buy	1,968 +78	+4%	+$14.5K	0.12%	131
2025 Q1	$396K	Buy	1,890 +121	+7%	+$23.5K	0.15%	117
2024 Q4	$314K	Buy	+1,769	New	+$325K	0.12%	131

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manske Wealth Management's ABBV Position: Q2 2026 in Review

Manske Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $5.38K and bringing the position to 1,894 shares worth $477K. The position accounts for 0.12% of the portfolio, ranked #139.

Manske Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Manske Wealth Management held 1,894 shares of AbbVie worth $477K as of Q2 2026.
Manske Wealth Management bought 25 AbbVie shares in Q2 2026, an estimated $5.38K.
AbbVie made up 0.12% of Manske Wealth Management's portfolio in Q2 2026, its #139 holding.
Manske Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.